Neuraxpharm stands as a leading European specialty pharmaceutical company, expertly focused on pioneering treatments for the central nervous system (CNS), addressing both psychiatric and neurological disorders. With over 40 years of dedicated experience, Neuraxpharm possesses an unparalleled understanding of the CNS market, consistently driving innovation through new products and solutions tailored to meet the evolving needs of patients. The company is actively expanding its comprehensive portfolio through strategic pipeline developments, partnerships, and acquisitions.
With a strong presence across more than 20 countries in Europe, two in Latin America, one in the Middle East, and one in Australia, Neuraxpharm operates with a dedicated team of approximately 1,000 employees. Additionally, Neuraxpharm extends its global reach through partnerships in over 50 countries. Backed by funds advised by Permira, Neuraxpharm ensures the highest standards of pharmaceutical product manufacturing at its state-of-the-art Neuraxpharm Pharmaceuticals facilities (formerly Laboratorios Lesvi) in Spain. The primary address of Neuraxpharm is Avda. Barcelona, 69, Sant Joan Despí, Barcelona 08970, ES.
Neuraxpharm is committed to advancing healthcare through innovative and effective CNS treatments. As the company continues to evolve and expand, more information will be completed soon with the support of the company’s management, ensuring that Neuraxpharm remains at the forefront of the pharmaceutical industry. We invite the manager of Neuraxpharm to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence and commercial development.
Neuraxpharm se erige como una empresa farmacéutica especializada líder en Europa, enfocada expertamente en tratamientos pioneros para el sistema nervioso central (SNC), abordando tanto trastornos psiquiátricos como neurológicos. Con más de 40 años de experiencia dedicada, Neuraxpharm posee una comprensión incomparable del mercado del SNC, impulsando constantemente la innovación a través de nuevos productos y soluciones diseñadas para satisfacer las necesidades cambiantes de los pacientes. La empresa está expandiendo activamente su cartera integral a través de desarrollos estratégicos de proyectos, asociaciones y adquisiciones.
Con una fuerte presencia en más de 20 países de Europa, dos en América Latina, uno en Oriente Medio y uno en Australia, Neuraxpharm opera con un equipo dedicado de aproximadamente 1000 empleados. Además, Neuraxpharm extiende su alcance global a través de asociaciones en más de 50 países. Respaldado por fondos asesorados por Permira, Neuraxpharm garantiza los más altos estándares de fabricación de productos farmacéuticos en sus modernas instalaciones de Neuraxpharm Pharmaceuticals (anteriormente Laboratorios Lesvi) en España. La dirección principal de Neuraxpharm es Avda. Barcelona, 69, Sant Joan Despí, Barcelona 08970, ES.
Neuraxpharm está comprometida con el avance de la atención médica a través de tratamientos innovadores y eficaces para el SNC. A medida que la empresa continúa evolucionando y expandiéndose, pronto se completará más información con el apoyo de la administración de la empresa, asegurando que Neuraxpharm se mantenga a la vanguardia de la industria farmacéutica. Invitamos al gerente de Neuraxpharm a crear una presentación de empresa y una lista de productos personalizadas y exclusivas en nuestra plataforma para mejorar aún más su presencia en el mercado y su desarrollo comercial.
Compare Neuraxpharm with 3 companies in Pharmaceutical-Manufacturing
| Comparison Field |
NeuraxpharmMain Company |
Kyowa Kirin Internat...View Profile |
Linux LifesciencesView Profile |
KURESYSView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1995 | 2019 | 2014 |
|
Company Size
|
— | 501-1,000 | 501-1,000 | 201-500 |
|
City
|
Sant Joan Despí, Barcelona | Galashiels, Selkirkshire | Pondicherry, Puducherry | NEW DELHI, Delhi |
|
Country
|
Spain | India | India | |
|
Skills & Keywords
Comparing with main company
|
25 Total Skills
Pharmaceutical Manufacturing
Central Nervous System Treatments
CNS Disorders
Psychiatric Treatments
Neurological Treatments
Specialty Pharmaceuticals
Pharmaceutical Innovation
Medical devices
CNS
Finished Dosage Forms (FDFs)
Consumer Healthcare
Psychiatry
Probiotics
R&D
Branded pharmaceuticals
CMO
Orphan drugs
Generic pharmaceuticals
Nutraceuticals
Pain
Value Added Medicines
Geriatric
Central Nervous System
Neurology
Biologic drugs
|
10 Total
10 Unique
Unique Skills:
Antibodies
Biopharmaceuticals
Biotechnology
Clinical Development
Drug Discovery
Hematology / Haematology
+4
|
17 Total
17 Unique
Unique Skills:
Best manufacturer
Cardiology
Contract Manufacturing Organization
Customised
Dermatology
Diabetology
+11
|
1 Total
1 Unique
Unique Skills:
GENERAL PRODUCTS
|
Other organizations in the same industry
This company is also known as